BOSTON, Aug. 4, 2010 (GLOBE NEWSWIRE) -- AG Mednet, the world's largest diagnostic imaging network, announced today that the U.S. Patent Office had granted the company patent number 7765109, "Systems and methods for providing diagnostic imaging studies to one or more interpreters and selecting one or more of the interpreters to provide an interpretation of the images based on one or more variables." The patent broadly encompasses a number of key innovations in the field, all of which are made a reality for the first time by AG Mednet to all its users worldwide. AG Mednet's unique ability to collect image exams, validate data, notify recipients and senders and capture submission metrics, makes it the most robust compliance, validation and management tool in the market.
"We are very pleased to receive this recognition," said Abraham Gutman, President & CEO of AG Mednet. He added: "We always thought that our approach to diagnostic image transfer was unique and practical. Our greatest satisfaction stems from the fact that we have over 6,000 registered users worldwide in over 50 countries. With over 90 clinical trials from every one of the top 10 pharmaceutical companies, the top biotech and device companies, as well as dozens of radiology departments around the world, this latest validation further demonstrates why our platform is rapidly becoming the global standard."
About AG Mednet
AG Mednet, which provides the largest HIPAA and 21 CFR Part 11 / GxP compliant diagnostic imaging network, routes a broad range of medical imaging modalities, including CT, MRI, ultrasound, PET and digital x-ray. The dedicated, carrier-class network is in use in every continent and over 50 countries, with over 6,000 registered users at investigator sites, bio-pharmaceutical and device companies, as well as top CROs and imaging core labs. The automated system, which enables the de-identification and secure, seamless electronic transfer of study data from sites to trial image repositories, enhances site compliance while providing detailed reporting for regulatory requirements.